These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7026969)

  • 1. Effect of intermittent physiologic hyperglucagonemia on postprandial plasma glucose levels in normal man.
    Mackes K; Rizza R; Gerich J
    Metabolism; 1981 Nov; 30(11):1041-4. PubMed ID: 7026969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.
    Fineman M; Weyer C; Maggs DG; Strobel S; Kolterman OG
    Horm Metab Res; 2002 Sep; 34(9):504-8. PubMed ID: 12384827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
    Leichter SB; Pagliara AS; Grieder MH; Pohl S; Rosai J; Kipnis DM
    Am J Med; 1975 Feb; 58(2):285-93. PubMed ID: 46704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglucagonemia in myotonic dystrophy.
    Suzuki H
    J Clin Endocrinol Metab; 1981 Apr; 52(4):790-5. PubMed ID: 7009630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
    Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
    Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate intolerance in gonadal dysgenesis: evidence for insulin resistance and hyperglucagonemia.
    Costin G; Kogut MD
    Horm Res; 1985; 22(4):260-9. PubMed ID: 3908274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of exaggerated glucagon response to arginine in diabetes mellitus.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes Res Clin Pract; 1985 Oct; 1(3):131-7. PubMed ID: 3915260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques.
    D'Alessio DA; Kieffer TJ; Taborsky GJ; Havel PJ
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1253-9. PubMed ID: 11238517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.
    Bomboy JD; Lewis SB; Lacy WW; Sinclair-Smith BC; Liljenquist JE
    Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
    Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
    J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
    Beard JC; Weinberg C; Pfeifer MA; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
    Levetan C; Want LL; Weyer C; Strobel SA; Crean J; Wang Y; Maggs DG; Kolterman OG; Chandran M; Mudaliar SR; Henry RR
    Diabetes Care; 2003 Jan; 26(1):1-8. PubMed ID: 12502651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.